On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction
- PMID: 8584425
- DOI: 10.1007/BF02207269
On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction
Abstract
Giant or slow-rising miniature end-plate potentials (GMEPPs) caused by vesicular release of acetylcholine (ACh) occur at any time in about 50% of mouse diaphragm neuro muscular junctions, but generally at frequencies less than 0.03 s-1. Their frequency is, unlike that of miniature end-plate potentials (MEPPs), not affected by nerve terminal depolarization. Unlike MEPPs and stimulus-evoked end-plate potentials, GMEPPs have a prolonged time-to-peak and show an increase in time-to-peak with amplitude. By using these differences in amplitude and time course, GMEPPs can be separated from MEPPs. In contrast to MEPPs, GMEPPs are not blocked by botulinum neurotoxin type A. GMEPPs have a greater temperature sensitivity than MEPPs, disappearing at temperatures below 15 degrees C. Long-term paralysis by botulinum toxin and certain drugs which inhibit protein kinase C or affect actin filament polymerization (cytochalasins) enhance the frequency of GMEPPs. End-plate current recordings show that similar postsynaptic ACh receptors are activated by MEPPs and GMEPPs. It is suggested that GMEPPs are not caused by mechanisms involved in regulated neurotransmitter release but are generated by constitutive secretion.
Similar articles
-
Giant miniature end-plate potentials at the untreated and emetine-treated frog neuromuscular junction.J Physiol. 1989 May;412:475-91. doi: 10.1113/jphysiol.1989.sp017627. J Physiol. 1989. PMID: 2600842 Free PMC article.
-
Emetine increases giant miniature endplate potential population at the frog neuromuscular junction.Brain Res. 1988 May 3;447(2):293-8. doi: 10.1016/0006-8993(88)91132-8. Brain Res. 1988. PMID: 3260532
-
Miniature endplate potentials induced by ammonium chloride, hypertonic shock, and botulinum toxin.J Neurosci Res. 1992 Feb;31(2):318-26. doi: 10.1002/jnr.490310213. J Neurosci Res. 1992. PMID: 1573682
-
Calcium-insensitive miniature endplate potentials at the neuromuscular junction.Synapse. 1987;1(4):281-92. doi: 10.1002/syn.890010402. Synapse. 1987. PMID: 2843994 Review.
-
Transmitter release: prepackaging and random mechanism or dynamic and deterministic process.Brain Res Brain Res Rev. 1990 May-Aug;15(2):167-78. doi: 10.1016/0165-0173(90)90017-i. Brain Res Brain Res Rev. 1990. PMID: 1980833 Review.
Cited by
-
Caffeine- and ryanodine-induced changes in the spectrum of spontaneously secreted quanta of the mediator in the neuromuscular synapse of mice.Dokl Biol Sci. 2001 Sep-Oct;380:435-7. doi: 10.1023/a:1012358902069. Dokl Biol Sci. 2001. PMID: 12918397 No abstract available.
-
Effects of 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one on synaptic vesicle cycling at the frog neuromuscular junction.J Neurosci. 2002 Dec 15;22(24):10680-9. doi: 10.1523/JNEUROSCI.22-24-10680.2002. J Neurosci. 2002. PMID: 12486161 Free PMC article.
-
Ablation of All Synaptobrevin vSNAREs Blocks Evoked But Not Spontaneous Neurotransmitter Release at Neuromuscular Synapses.J Neurosci. 2019 Jul 31;39(31):6049-6066. doi: 10.1523/JNEUROSCI.0403-19.2019. Epub 2019 Jun 3. J Neurosci. 2019. PMID: 31160536 Free PMC article.
-
Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase.PLoS One. 2014 Aug 5;9(8):e104081. doi: 10.1371/journal.pone.0104081. eCollection 2014. PLoS One. 2014. PMID: 25093813 Free PMC article.
-
Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.Br J Pharmacol. 2005 Aug;145(7):954-62. doi: 10.1038/sj.bjp.0706248. Br J Pharmacol. 2005. PMID: 15880138 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources